VEGF gene delivery to muscle: Potential role for vasculogenesis in adults

被引:289
作者
Springer, ML
Chen, AS
Kraft, PE
Bednarski, M
Blau, HM [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA
关键词
D O I
10.1016/S1097-2765(00)80154-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Constitutive expression of VEGF after implantation of genetically engineered myoblasts into non-ischemic muscle led to an increase in vascular structures. Previously, effects of VEGF delivery to adult muscle have only been reported in ischemic tissues. The resulting vascular structures were reminiscent of those formed during embryonic vasculogenesis, rather than angiogenesis, sprouting from preexisting vessels. Initially, VEGF caused an accumulation of endothelial cells and macrophages, followed by networks of vascular channels and hemangiomas with locally high serum VEGF levels. No effects were evident in adjacent tissue or contralateral legs, where low serum VEGF was detected. These data suggest that the induction by VEGF of angiogenesis or vasculogenesis may be dose-dependent. Furthermore, VEGF expression must be carefully modulated, as overexpression is deleterious.
引用
收藏
页码:549 / 558
页数:10
相关论文
共 67 条
[1]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[2]   F4-80, A MONOCLONAL-ANTIBODY DIRECTED SPECIFICALLY AGAINST THE MOUSE MACROPHAGE [J].
AUSTYN, JM ;
GORDON, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (10) :805-815
[3]  
BALDWIN HS, 1994, DEVELOPMENT, V120, P2539
[4]   ANGIOGENIC-INDUCED ENHANCEMENT OF COLLATERAL BLOOD-FLOW TO ISCHEMIC MYOCARDIUM BY VASCULAR ENDOTHELIAL GROWTH-FACTOR IN DOGS [J].
BANAI, S ;
JAKLITSCH, MT ;
SHOU, M ;
LAZAROUS, DF ;
SCHEINOWITZ, M ;
BIRO, S ;
EPSTEIN, SE ;
UNGER, EF .
CIRCULATION, 1994, 89 (05) :2183-2189
[5]   UP-REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION INDUCED BY MYOCARDIAL-ISCHEMIA - IMPLICATIONS FOR CORONARY ANGIOGENESIS [J].
BANAI, S ;
SHWEIKI, D ;
PINSON, A ;
CHANDRA, M ;
LAZAROVICI, G ;
KESHET, E .
CARDIOVASCULAR RESEARCH, 1994, 28 (08) :1176-1179
[6]   SYSTEMIC DELIVERY OF RECOMBINANT PROTEINS BY GENETICALLY MODIFIED MYOBLASTS [J].
BARR, E ;
LEIDEN, JM .
SCIENCE, 1991, 254 (5037) :1507-1509
[7]   SITE-SPECIFIC THERAPEUTIC ANGIOGENESIS AFTER SYSTEMIC ADMINISTRATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
BAUTERS, C ;
ASAHARA, T ;
ZHENG, LP ;
TAKESHITA, S ;
BUNTING, S ;
FERRARA, N ;
SYMES, JF ;
ISNER, JM .
JOURNAL OF VASCULAR SURGERY, 1995, 21 (02) :314-325
[8]   MUSCLE-MEDIATED GENE-THERAPY [J].
BLAU, HM ;
SPRINGER, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1554-1556
[9]   Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts [J].
Bohl, D ;
Naffakh, N ;
Heard, JM .
NATURE MEDICINE, 1997, 3 (03) :299-305
[10]  
BOOTH CJ, 1995, LAB ANIM SCI, V45, P497